| Balance Sheet Details |
3. Balance Sheet Details Prepaid Expenses and Other Current Assets Prepaid expenses and other current assets consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30,
2026 |
|
|
December 31,
2025 |
|
Prepaid insurance costs |
|
$ |
36,875 |
|
|
$ |
19,375 |
|
Other prepaid expenses & current assets |
|
|
109,641 |
|
|
|
33,948 |
|
Deposit on lab equipment |
|
|
— |
|
|
|
57,974 |
|
Total prepaid expenses & current assets |
|
$ |
146,516 |
|
|
$ |
111,297 |
|
Property and Equipment, Net Property and equipment, net consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30,
2026 |
|
|
December 31,
2025 |
|
Lab equipment |
|
$ |
252,703 |
|
|
$ |
117,055 |
|
Furniture & fixtures |
|
|
33,833 |
|
|
|
— |
|
Total property and equipment, gross |
|
|
286,536 |
|
|
|
117,055 |
|
Accumulated depreciation |
|
|
(122,689 |
) |
|
|
(98,988 |
) |
Total property and equipment, net |
|
$ |
163,847 |
|
|
$ |
18,067 |
|
Depreciation expense was $8,185 and $6,765 for the three months ended September 30, 2026 and 2025, respectively. Depreciation expense was $23,701 and $21,206 for the nine months ended September 30, 2026 and 2025, respectively. Accrued Expenses Accrued expenses consisted of the following:
|
|
|
|
|
|
|
|
|
|
|
September 30,
2026 |
|
|
December 31,
2025 |
|
Accrued payroll and related expenses |
|
$ |
795,979 |
|
|
$ |
1,187,636 |
|
Accrued clinical development costs |
|
|
84,445 |
|
|
|
78,935 |
|
Accrued professional fees |
|
|
28,500 |
|
|
|
67,986 |
|
Accrued clinical study expenses |
|
|
4,609 |
|
|
|
30,999 |
|
Accrued other expenses |
|
|
2,627 |
|
|
|
32,088 |
|
Total accrued expenses |
|
$ |
916,160 |
|
|
$ |
1,397,644 |
|
|